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ABSTRACT 
 
The etiology of periodontitis is multifactorial and the anatomical complexity of tooth roots serves as niches for 
bacterial deposits, making eradication of periodontopathogens more difficult both mechanically and chemically.   
Also, the fact that conventional treatment such as scaling and root planing (SRP) does not completely eliminate 
periodontal pathogens, led to the use of various adjuvant treatments modalities.  A novel noninvasive photochemical 
approach for infection control, namely photodynamic therapy, has received much attention in the treatment of oral 
diseases. Three nontoxic ingredients namely visible harmless light, a photosensitizer and oxygen are involved in this 
therapy. It is based on the principle that a photosensitizer binds to the target cells which when activated by light of a 
suitable wavelength results in the production of singlet oxygen and other very reactive agents that are extremely 
toxic to certain cells and bacteria. This article highlights the role of photodyanamic therapy in periodontitis. 
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INTRODUCTION  
  
The application of light energy (phototherapy) has been 
considered as a novel treatment approach in periodontics. 
Dental lasers have been used as an effective means of 
decontamination of periodontal pockets over a period of 
20 years[1]. Lasers possess high bactericidal properties 
and have demonstrated effective killing of oral 
pathogenic bacteria associated with periodontitis and 
peri-implantitis[2]. Most high-level lasers exhibit 
bactericidal effects by thermal denaturation or direct 
ablation or destruction of bacterial cells and have been 
applied in nonsurgical or surgical periodontal and peri-
implant therapies. 
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Besides damaging the bacterial cells, the use of high-
level lasers results in irreversible thermal damage to the 
surrounding periodontal tissues, excessive ablation or 
thermal coagulation, carbonization or necrosis of the 
root, the gingival connective tissue, the bone and the 
pulp tissues, depending on the type of laser 
employed[3].Photodynamic therapy is a new type of 
noninvasive phototherapy for bacterial elimination, 
which uses low-level laser light and selectively targets 
the bacteria without potentially damaging the host 
tissues[1]. 
 
Historical perspective of photodynamic therapy  
 
The origin of light as a therapy in medicine and surgery 
has been traced from antiquity to the modern day. 
Phototherapy began in ancient Greece, Egypt and India, 
but disappeared for many centuries, only being 
rediscovered by the Western civilization at the beginning 
of the 20th century. The use of contemporary 
photodynamic therapy was first reported by the Danish 
physician, Niels Finsen (1901). He successfully 
demonstrated photodynamic therapy by employing heat 
– filtered light from a carbon – arc lamp (The Finsen 
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Lamp) in the treatment of a tubercular condition of the 
skin known as Lupus Vulgaris. Niels Finsen won a nobel 
prize for his work on phototherapy in 1903. [1,4] 
The concept of cell death induced by the interaction of 
light and chemicals was first reported by Osar Raab[5] a 
medical student working with Professor Herman Von 
Tappeiner in Munich. During the course of his study on 
the effects of acridine on paramecia cultures, he 
discovered that the combination of acridine red and light 
had a lethal effect on infusoria, a species of paramecium. 
Subsequent work in the laboratory of Von Tappeiner 
(1907) coined the term “Photodynamic action” and 
showed that oxygen was essential. Much later, Thomas 
Dougherty and co-worker[6] at Roswell Park cancer 
institute, Buffalo, New York, clinically tested 
Photodynamic therapy. In 1978, they published striking 
results in which they treated 113 cutaneous or 
subcutaneous malignant tumors and observed a total or 
partial resolution of 111 tumors. The active 
photosensitizer used in this clinical trial was called 
Hematoporphyrin Derivative. It was John Toth, who 
renamed it as Photodynamic therapy. 
Photodynamic therapy was approved by the Food and 
Drug Administration in 1999 to treat pre-cancerous skin 
lesions of the face or scalp. PDT has emerged in recent 
years as a new non - invasive therapeutic option. 
Components of PDT 
Photodynamic therapy basically involves three non-toxic 
ingredients: visible harmless light, a nontoxic 
photosensitizer and oxygen. (Figure 1) It is based on the 
principle that a photosensitizer (i.e. a photoactivatable 
substance) binds to the target cells and is activated by 
light of a suitable wavelength. Following activation of 
the photosensitizer through the application of light of a 
certain wavelength, singlet oxygen and other very 
reactive agents are produced that are extremely toxic to 
certain cells and bacteria. The photosensitizer is 
generally applied in the targeted area by topical 
application, aerosol delivery or interstitial injection. The 
light that activates the photosensitizer must be of a 
specific wavelength with a relatively high intensity[1].
 
 
            
Figure 1: Basic components of photodynamic therapy 
 
Light 
 
Sources of light include a range of lasers, helium - neon 
lasers (633 nm), gallium - aluminum - arsenide diode 
lasers (630-690, 830 or 906 nm) and argon laser (488-
514nm), the wavelength of which range from visible 
light to the blue of argon lasers, or from the red of 
helium-neon laser to the infra red area of diode lasers. 
Non-laser light sources like light emitting diode (LED) 
and light cure units. Photosensitizers are activated by red  
 
 
light between 630 and 700 nm corresponding to a light 
penetration depth from 0.5 cm (at 630 nm) to 1.5 cm at 
(700 nm) which is sufficient for periodontal treatment.[7] 
The total light dose, dose rates and the depth of 
destruction vary with each tissue treated and 
photosensitizer used[8]. 
 
 
Light
OxygenPhotosensitizer
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Photosensitizers 
 
A photosensitizer is a dye substance that is absorbed by 
the microorganism, cell or tissue allowing it to interact 
with the light.  An optimal photo sensitizer must possess 
photo-physical, chemical and biological characteristics. 
The sensitizers used for medical purposes belong to the 
following basic structure: [7] 
1. Tricyclic dyes with different meso-atoms E.g.: 
Acridine orange, proflavine, riboflavin, 
methylene blue, fluorescein and erythrosine. 
2. Tetrapyrroles. E.g.: Porphyrins and derivatives, 
chlorophyll, phylloerythrin and 
phthalocyanines. 
3. Furocoumarins. E.g.: Psoralen and its 
methoxyderivatives, xanthotoxin and 
bergaptene.  
 
In antimicrobial PDT, photosensitizers used are toluidine 
blue O and methylene blue. Both have similar chemical 
and physicochemical characteristics. The positive charge 
seems to promote the binding of the photosensitizer to 
the gram-negative bacterial membrane and leads to its 
localized damage, resulting in an increase in its 
permeability.  Methylene blue interaction with the 
anionic lipopolysaccharide macromolecule of gram-
negative bacteria results in the generation of methylene 
blue dimers, which participate in the photosensitization 
process [9,10] 
 
Mechanism of action 
 
The bactericidal effect of photodynamic therapy is 
explained by two potential, but different, mechanisms 
namely the DNA damage and the damage caused to the 
cytoplasmic membrane of the bacteria by cytotoxic 
species generated by antimicrobial photodynamic 
therapy. After irradiation with light of a specific 
wavelength (lasers), the photosensitizer at ground state is 
activated to a highly energized triplet state. The longer 
lifetime of the triplet state enables the interaction of the 
excited photo sensitizer with the surrounding molecules 
resulting in the generation of cytotoxic species. There are 
two different pathways (type I and II) to react with 
biomolecules. [1,11] 
 
Type I reactions involve hydrogen-atom abstraction or 
electron-transfer reactions between the excited state of 
the photosensitizer and an organic substrate molecule of 
the cells, which produces free radicals and radical ions. 
These free-radical species are highly reactive and 
interact with endogenous molecular oxygen to produce 
highly reactive oxygen species such as superoxide, 
hydroxyl radicals and hydrogen peroxide, which are 
harmful to cell membrane integrity and result in 
irreparable biological damage [11]. (Figure 2) 
 
In the type II reaction, the triplet-state photosensitizer 
reacts with oxygen to produce a highly reactive state of 
oxygen, known as singlet oxygen (1O2), which interacts 
with a large number of biological substrates due to its 
high chemical reactivity, inducing oxidative damage and 
ultimately lethal effects upon the bacterial cell by 
damaging the cell membrane and cell wall. Singlet 
oxygen has a short lifetime in biological systems (<0.04 
µs) and a very short radius of action (0.02 µm) that 
causes limited migration of singlet oxygen from its site 
of formation  leading to a localized response and making 
it ideal for application at localized sites without affecting 
distant molecules, cells or organs. The process of 
antimicrobial photodynamic therapy is generally 
mediated by a type II reaction, which is accepted as the 
major pathway in microbial cell damage.[11,12] (Figure 2) 
  
Figure 2: Mechanism of photodynamic antimicrobial reaction at the molecular level[1] 
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Photodynamic therapy in the treatment of oral 
diseases  
 
Applications of photodynamic therapy in dentistry 
include photodynamic diagnosis of malignant oral 
lesions, treatment of premalignant and malignant oral 
lesions and photodynamic antimicrobial chemotherapy 
(PACT) of bacterial and fungal infections. The various 
uses are as follows: [1, 13] 
1. Treatment of different types of oral solid tumors 
2. Treatment of psoriasis, actinic keratosis 
3. Treatment of inflammatory diseases like 
rheumatoid arthritis 
4. Age related macular degeneration 
5. Superficial precancerous oral lesions, such as 
oral leukoplakia, oral erythroleukoplakia, oral 
verrucous hyperplasia and lichen planus. 
6. Treatment of Bacterial, fungal and viral 
infections of the oral cavity.  
7. Treatment and prevention of dental caries.  
8. As an adjunct to conventional endodontic 
disinfection treatment to destroy the bacteria 
that remain even after irrigation with sodium 
hypochlorite 
9. Effective in the destruction of Candida albicans, 
which is responsible for oropharyngeal 
candidiasis 
10. Elimination of bacteria in supragingival and 
subgingival plaque. 
11. As an adjunctive for bacterial elimination in the 
treatment of periimplantitis 
 
Photodynamic therapy and Periodontitis 
 
Biofilm in oral cavity causes two of the most common 
diseases, dental caries and periodontal diseases. An 
effective approach of periodontal therapy is to change 
the local environment to suppress the growth of 
periodontal pathogens. Using antimicrobial agents to 
treat periodontitis without disruption of the biofilm 
ultimately results in treatment failures. It is difficult to 
maintain therapeutic concentrations at the target sites and 
target organisms can develop resistance to drugs. This 
resistance is minimized by using PDT. Polysaccharides 
present in extracellular matrix of oral biofilm are highly 
sensitive to singlet oxygen and susceptible to 
photodamage. Breaking the biofilm may inhibit plasmid 
exchange involved in transfer of antibiotic resistance and 
disrupt colonization[14,15] Photodynamic antimicrobial 
chemotherapy could be an ideal complement to 
conventional scaling and root planing. However, 
bacterial eradication from dental plaque-derived biofilms 
is still at a lower level compared to the planktonic 
condition. In the study conducted by Fontana et al [16] 
photodynamic therapy eliminated approximately 63% of 
bacteria in the planktonic phase as compared to 32% of 
bacteria in biofilms, derived from the same plaque 
samples. 
 
During inflammation there is venous stagnation and 
reduced oxygen consumption by tissues. This decrease in 
oxygen level and change in pH enhances the growth of 
anaerobic species. PDT improves tissue blood flow in 
the microcirculatory system and reduces venous 
congestion in gingival tissues. Furthermore, PDT 
increases oxygenation of gingival tissues by 21–47 per 
cent which in turn decreases the time and speed of 
oxygen delivery and utilization, thus normalizing oxygen 
metabolism in periodontal tissues [17] 
 
The pathogenesis of periodontal diseases is explained on 
the basis of the virulence factors possessed by the 
periodontopathogens that cause activation of 
macrophages, production of interleukin-1, release of 
prostaglandin E2, which are potent stimulators of bone 
resorption.  Endotoxin on root surface inhibits fibre 
reattachment on cementum. PDT causes the inactivation 
of the various virulence factors secreted by micro-
organisms. [18] 
 
Upon interpretation of the data from  various controlled 
clinical studies, the adjunctive use of PDT to scaling and 
root planning in the treatment of patients with chronic 
periodontitis, aggressive periodontitis and peri-
implantitis, resulted in greater clinical attachment level 
gains, reduction in bleeding on probing and probing 
pocket depths. Azarpazhooh et al[19] conducted a 
systemic review and concluded that photodynamic 
therapy as an independent therapy or as an adjunct to 
SRP was not superior to control treatment than SRP. A 
meta-analysis was performed by Sgolastra et al[20] 
which suggested that the use of aPDT as an adjunct to 
conventional treatment provides short-term benefits in 
terms of CAL gain and pocket depth reduction (at 3 
months after treatment ) thereby confirming the safety of 
PDT. 
 
PDT has advantage such as reducing the treatment time 
(<60seconds), no need for anesthesia, destruction of 
bacteria, inactivation of endotoxins, non-invasive local 
therapy, reduced risk of bacteraemia after periodontal 
debridement and no damage to the adjacent host 
tissues[14,21]. 
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Current status and future perspectives 
In the dental field, photodynamic therapy is approved for 
the palliative treatment of patients with advanced head 
and neck cancer and in the treatment of various oral 
lesions. Photo-activated disinfection system, PADTM 
(Denfotex Light Systems Ltd, Inverkeithing, UK), is 
used for the disinfection of root canals. The PADTM 
consists of toluidine blue O solution and a 100 mW 
diode laser that emits light at 635 nm. Toluidine blue O 
(12.7 mg ⁄l) is applied in the root canals for 60 seconds 
followed by exposure to light via a fiberoptic for 2 min. 
Photodynamic therapy rapidly eliminates 
microorganisms unlike the conventional therapy[22]. 
Recently, in Canada, the product called Periowave 
(http://www.periowave.com) was commercialized by 
Ondine Biopharma Corporation 
(http://www.ondinebiopharma.com) for the treatment of 
periodontitis. The Periowave product consists of a laser 
system with a custom-designed handpiece and patient 
treatment kits of methylene blue. A kit that includes 
phenothiazine chloride for clinical photodynamic therapy 
is now available in Austria, Germany, Switzerland and 
the UK (Helbo; Photodynamic Systems GmbH & Co. 
KG, Grieskirchen, Austria). Similar kits that include 
toluidine blue O are also available from other companies, 
including Denfotex Ltd., Dexcel Pharma Technologies 
Ltd., SciCan Medtech AG and Cumdente 
GmbH[22].(Figure 3,4) 
 
The application of these kits is very simple and 
convenient. Methylene blue is applied directly in the 
dental pockets for 60 seconds followed by exposure to 
red light via a fiberoptic probe for 60 seconds per pocket 
or per tooth (10s per site, six sites in total). In the 
majority of the studies, photodynamic therapy was used 
as an adjunct to scaling and root planing. (Figure 5) 
 
 
 
Figure 3: Periowave  
 
                Figure 4: Helbo® T-Controller 
            (From: www.bredent-medical.com) 
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Figure 5: Steps of application of photodynamic therapy in the treatment of periodontitis. 
(A) Periodontally diseased site before treatment. (B) Mechanical debridement using hand curettes. (C)Application of 
the photosensitizer via syringe at the diseased site that contains residual bacteria. (D) Photosensitization is performed 
using an intensive light by a special tip applied in the pocket. Singlet oxygen and other very reactive agents that are 
toxic to bacteria are produced, resulting in photochemical disinfection of the periodontal pocket. (E) Improved wound 
healing in the treated site.[1] 
 
CONCLUSION 
 
Antimicrobial photodynamic therapy is likely to be an at-
tractive option as a non-invasive treatment approach in 
the field of periodontology, with confirmed clinical 
safety. Antimicrobial photodynamic treatment has been 
reported to be effective as an adjunct to conventional 
therapy to destroy bacteria in sites where there is limited 
access for mechanical instrumentation as a result of the 
anatomical complexity of the roots. Also, further 
randomized long-term clinical studies and meta-analyses 
are necessary to demonstrate the beneficial effects of 
antimicrobial photochemical therapy and their real 
advantages in comparison with conventional methods. 
Only then antimicrobial photodynamic therapy will hold 
promise as a substitute for currently available 
chemotherapy in the treatment of periodontal and peri-
implant diseases. 
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